SCHEMBL6560967

SCHEMBL6560967

CC(C)=CCCC(C)CCOC(=O)C(=O)c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.58
NFE2L2 Q16236 1/20 0.44
ALDH1A1 P00352 2/20 0.41
ATM Q13315 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KDM4E B2RXH2 1/20 0.39
TSHR P16473 1/20 0.39
MAPT P10636 2/20 0.38
EPHX2 P34913 1/20 0.37
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
TRPV1 Q8NER1 1/20 0.36
USP2 O75604 1/20 0.36
LMNA P02545 1/20 0.36
XBP1 P17861 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14993184 0.90 ALOX15 (0.58) ALOX15NFE2L2ALDH1A1L3MBTL1KDM4E
SCHEMBL14993006 0.88 ALOX15 (0.46) ALOX15NFE2L2ALDH1A1ATMTDP1
SCHEMBL6561525 0.87 CES2 (0.44) ALOX15ALDH1A1TDP1MAPTCES2
SCHEMBL585939 0.86 ALOX15 (0.61) ALOX15NFE2L2ALDH1A1TDP1TRPV1
SCHEMBL5605056 0.86 ALOX15 (0.61) ALOX15NFE2L2ALDH1A1TDP1TRPV1
SCHEMBL5605059 0.86 ALOX15 (0.61) ALOX15NFE2L2ALDH1A1TDP1TRPV1
SCHEMBL14844455 0.85 ALOX15 (0.53) ALOX15NFE2L2ALDH1A1KDM4ETSHR
SCHEMBL6560284 0.82 ALOX15 (0.50) ALOX15NFE2L2ALDH1A1KDM4ETSHR
SCHEMBL6560209 0.81 ALOX15 (0.80) ALOX15NFE2L2ALDH1A1TDP1TSHR
SCHEMBL7935247 0.80 ALOX15 (0.53) ALOX15TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2822682-B1 MICROCAPSULES AND USES THEREOF FIRMENICH & CIE (CH) 2017-04-26 EP claimed
CN-103958047-B Microcapsules and their use 弗门尼舍有限公司 2017-03-01 CN claimed
US-9334464-B2 Microcapsules and uses thereof FIRMENICH SA (CH) 2016-05-10 US claimed
EP-2822682-A1 MICROCAPSULES AND USES THEREOF Firmenich SA (CH) 2015-01-14 EP claimed
US-20140323376-A1 MICROCAPSULES AND USES THEREOF FIRMENICH SA (CH) 2014-10-30 US claimed
CN-103958047-A Microcapsules and their use FIRMENICH & CIE 2014-07-30 CN claimed
WO-2013079435-A1 MICROCAPSULES AND USES THEREOF FIRMENICH SA (CH) 2013-06-06 WO claimed
US-12264295-B2 Encapsulated pro-perfume compounds FIRMENICH SA (CH) 2025-04-01 US disclosed
US-20230093639-A1 PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT FIRMENICH SA (CH) 2023-03-23 US disclosed
US-20230032098-A1 ENCAPSULATED PRO-PERFUME COMPOUNDS FIRMENICH SA (CH) 2023-02-02 US disclosed
EP-4084769-A1 PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT Firmenich SA (CH) 2022-11-09 EP disclosed
CN-115175658-A Perfume system for perfumed consumer products 弗门尼舍有限公司 2022-10-11 CN disclosed
EP-3942009-A1 ENCAPSULATED PRO-PERFUME COMPOUNDS Firmenich SA (CH) 2022-01-26 EP disclosed
US-6492323-B2 CONTROLLED RELEASE UPON EXPOSURE TO LIGHT FIRMENICH SA (CH) 2002-12-10 US disclosed
US-6369026-B1 FOR USE IN PERFUME OR A COLOGNE, A BATH OR SHOWER GEL, A SHAMPOO, A HAIR SPRAY OR OTHER HAIR-CARE PRODUCT, A COSMETIC PREPARATION, A BODY DEODORANT, A SOLID OR LIQUID AIR-FRESHENER, A DETERGENT OR A FABRIC SOFTENER FIRMENICH SA (CH) 2002-04-09 US disclosed
US-20010014661-A1 Slow release of fragrant compounds in perfumery using alpha-keto esters FIRMENICH SA (CH) 2001-08-16 US disclosed
US-6218355-B1 FOR RELEASING FRAGRANT COMPOUND OR COMPOUNDS IN A CONTROLLED MANNER, MAINTAINING A DESIRED SMELL OVER A PROLONGED PERIOD OF TIME FIRMENICH SA (CH) 2001-04-17 US disclosed
EP-1082287-A2 SLOW RELEASE OF FRAGRANT COMPOUNDS IN PERFUMERY USING 2-BENZOYL BENZOATES, 2-ALKANOYL BENZOATES OR ALPHA-KETO ESTERS FIRMENICH SA (CH) 2001-03-14 EP disclosed
US-6133228-A Slow release of fragrant compounds in perfumery using 2-benzoyl benzoates, 2-alkanoyl benzoates or α-keto esters FIRMENICH SA (CH) 2000-10-17 US disclosed
WO-1999060990-A2 SLOW RELEASE OF FRAGRANT COMPOUNDS IN PERFUMERY USING 2-BENZOYL BENZOATES, 2-ALKANOYL BENZOATES OR α-KETO ESTERS FIRMENICH S.A. (CH) 1999-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010014661-A1 Slow release of fragrant compounds in perfumery using alpha-keto esters FAAH, KHK, FAAH2 ALOX15 265/4885NFE2L2 3503/4885ALDH1A1 122/4885
US-20230093639-A1 PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT PORCN, FAAH2, FASN ALOX15 115/4885NFE2L2 537/4885ALDH1A1 817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.